Equity Profile

BAX

Baxter International Inc.

Health CareHealth Care Equipment$14.0B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Baxter International Inc. (BAX) is a healthcare company that develops and provides a range of medical products, including equipment for renal and hospital care....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

0.54

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

2.9B

Wall Street expectations, options signals, track record, and call prep available with Pro.

BAX Q2-2026 Earnings Preview

Context

Company Snapshot

Baxter International Inc. (BAX) is a healthcare company that develops and provides a range of medical products, including equipment for renal and hospital care. With a market cap of $14 billion, Baxter plays a crucial role in the healthcare sector, particularly in addressing patient needs through innovative medical technologies.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+5.06%

Avg Stock Reaction

-4.92%

Last Quarter Recap

In Q1-2026, Baxter reported an EPS of $0.36, beating expectations by 15.38%. The stock reacted positively, gaining 4.02% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Baxter to report an EPS of $0.54 and revenue of $2.9 billion for Q2-2026, reflecting cautious optimism about the company's performance.

Bull Case

If Baxter meets or exceeds EPS estimates, it could signal strong demand for its products and improve investor confidence.

Bear Case

Conversely, if the company misses EPS or revenue expectations, it may raise concerns about its growth trajectory and market competitiveness.

Key Metrics to Watch

Earnings Per Share (EPS)

0.54

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue

2.9B

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Baxter's EPS exceed the consensus estimate of $0.54?

A strong EPS could indicate robust operational performance and boost investor sentiment.

How does Baxter's revenue of $2.9 billion compare to expectations?

Revenue performance is critical for assessing market demand and the company's growth prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Baxter to exceed EPS expectations due to recent product launches that have not been fully factored into projections.

Supporting Evidence

Baxter's recent product innovations could drive higher-than-expected sales, particularly in renal care.

The options market is pricing a smaller move than historical averages, suggesting that expectations may be too low.

Key Risk

If revenue growth exceeds $2.9 billion, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will reflect Baxter's ability to navigate market conditions and meet investor expectations.

Bull Confirmed If

An EPS of $0.54 or higher would confirm the bullish case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.50 would suggest significant challenges, confirming the bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±6.74%

Historical Avg

±9.7%

Pricing cheap

The options market is pricing in a potential move of about 6.74% in either direction following the earnings report.

Options are pricing ±6.7% while BAX has averaged ±9.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

40.0%

Calls (51K)P/C Ratio: 0.52Puts (20K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Baxter beats expectations, history suggests the stock could rise by about 0.59%, confirming positive market sentiment.

In-Line / Cautious

An in-line report may lead to mixed reactions, with management commentary driving the stock's direction.

Miss

If the company misses expectations, history indicates a potential drop of around 14.10%, raising concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their impact on sales.
2Management's outlook on market conditions and demand for healthcare products.
3Insights into cost management strategies and their effect on margins.
4Comments on competitive pressures in the healthcare equipment sector.
5Guidance on future revenue growth and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Baxter International Inc. (BAX) is a healthcare company that develops and provides a range of medical products, including equipment for renal and hospital care....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

0.54

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

2.9B

Wall Street expectations, options signals, track record, and call prep available with Pro.

BAX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+5.06%

Avg Stock Reaction

-4.92%

Last Quarter Recap

In Q1-2026, Baxter reported an EPS of $0.36, beating expectations by 15.38%. The stock reacted positively, gaining 4.02% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Baxter to report an EPS of $0.54 and revenue of $2.9 billion for Q2-2026, reflecting cautious optimism about the company's performance.

Bull Case

If Baxter meets or exceeds EPS estimates, it could signal strong demand for its products and improve investor confidence.

Bear Case

Conversely, if the company misses EPS or revenue expectations, it may raise concerns about its growth trajectory and market competitiveness.

Key Metrics to Watch

Earnings Per Share (EPS)

0.54

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue

2.9B

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Baxter's EPS exceed the consensus estimate of $0.54?

A strong EPS could indicate robust operational performance and boost investor sentiment.

How does Baxter's revenue of $2.9 billion compare to expectations?

Revenue performance is critical for assessing market demand and the company's growth prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Baxter to exceed EPS expectations due to recent product launches that have not been fully factored into projections.

Supporting Evidence

Baxter's recent product innovations could drive higher-than-expected sales, particularly in renal care.

The options market is pricing a smaller move than historical averages, suggesting that expectations may be too low.

Key Risk

If revenue growth exceeds $2.9 billion, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will reflect Baxter's ability to navigate market conditions and meet investor expectations.

Bull Confirmed If

An EPS of $0.54 or higher would confirm the bullish case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.50 would suggest significant challenges, confirming the bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±6.74%

Historical Avg

±9.7%

Pricing cheap

The options market is pricing in a potential move of about 6.74% in either direction following the earnings report.

Options are pricing ±6.7% while BAX has averaged ±9.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

40.0%

Calls (51K)P/C Ratio: 0.52Puts (20K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Baxter beats expectations, history suggests the stock could rise by about 0.59%, confirming positive market sentiment.

In-Line / Cautious

An in-line report may lead to mixed reactions, with management commentary driving the stock's direction.

Miss

If the company misses expectations, history indicates a potential drop of around 14.10%, raising concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their impact on sales.
2Management's outlook on market conditions and demand for healthcare products.
3Insights into cost management strategies and their effect on margins.
4Comments on competitive pressures in the healthcare equipment sector.
5Guidance on future revenue growth and market expansion plans.